Keywords: HCC, hepatocellular carcinoma; IR, immune repertoire; CDR, complementarity-determining regions; TCRs, T cell receptors; BCRs, B cell receptors; MRD, minimal residual disease; HTS, high-throughput sequencing; IR-SEQ, immune repertoire sequencing; TILs, tum